A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Masonic Cancer Center, University of Minnesota
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Columbia University
University Hospital, Basel, Switzerland
University of Nebraska
Asana BioSciences
Bellicum Pharmaceuticals
Chinese PLA General Hospital
Incyte Corporation
Novartis
Masonic Cancer Center, University of Minnesota
Mirror Biologics, Inc.
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Singapore General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Targazyme, Inc.
National Cancer Institute (NCI)
Asan Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center